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ABSTRACT: Deamidation of asparagine is a spontaneous and irreversible
post-translational modification associated with a growing list of human
diseases. While pervasive, deamidation is often overlooked because it
represents a relatively minor chemical change. Structural and functional
characterization of this modification is complicated because deamidation of
asparagine yields four isomeric forms of Asp. Herein, radical directed
dissociation (RDD), in conjunction with mass spectrometry, is used to
identify and quantify all four isomers in a series of model peptides that were
subjected to various deamidation conditions. Although primary sequence
significantly influences the rate of deamidation, it has little impact on the
relative proportions of the product isomers. Furthermore, the addition of
ammonia can be used to increase the rate of deamidation without
significantly perturbing isomer populations. Conversely, external factors
such as buffer conditions and temperature alter product distributions but
exhibit less dramatic effects on the deamidation rate. Strikingly, the common laboratory and biologically significant bicarbonate
buffer is found to strongly promote racemization, yielding increased amounts of D-Asp and D-isoAsp. These outcomes following
deamidation have broad implications in human aging and should be considered during the development of protein-based
therapeutics.
Post-translational modifications (PTMs) behave as powerfulregulatory elements that often define protein function
through covalent modification. Because PTMs profoundly
affect protein behavior, they are typically tightly controlled,
and dysregulation is strongly associated with numerous
diseases.1 Deamidation is an exception among PTMs due to
its nonenzymatic and spontaneous nature. Consequently, it is
both unregulated and irreversible. The inevitable nature and
predictable rate of this modification prompted the idea that
deamidation may have been engineered as a molecular clock
that signals protein aging and turnover.2 Although there are
select examples of deamidation serving functional roles, it is
generally considered to represent degradation3 and is associated
with a growing list of age-related, neurological, aggregation-
prone, and autoimmune diseases.4
While the implications of asparagine deamidation are
becoming increasingly apparent, the specific structural out-
comes have not been well-defined because the reaction yields
four isomeric products: L-Asp, D-Asp, L-isoAsp, and D-isoAsp
(see Scheme 1). All deamidation pathways introduce a
negatively charged side chain under physiological conditions,
but each of the four isomers is additionally likely to impact
structure and function in distinct ways. Although L-Asp and D-
Asp differ by only a single chiral center (thus making peptide
epimers when present in pairs that otherwise have the same
sequence), D-amino acids are known to have a profound impact
on peptide function. For instance, the D-Ala epimer of the
peptide opioid dermorphin (YAFGYPS) is ∼1000 times more
potent than morphine, while the L-Ala epimer is biologically
inactive.5 Unlike dermorphin, which is enzymatically modified
in tree frogs (Phyllomedusa sauvagei), D-amino acids accumulate
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Scheme 1. Deamidation Proceeds via an Intramolecular
Nucleophilic Attacka
aThe succinimide (Suc) intermediate is prone to racemization and
hydrolysis yielding four Asp isomers.
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in human proteins due to aging. Recently, racemization was
reported to be the most abundant PTM in aged lens proteins.6
Furthermore, D-Ser epimers have been shown to contribute to
the toxicity of β-amyloid in vivo.7 In addition to yielding
racemized Asp, deamidation produces isoAsp, which incorpo-
rates a methylene group into the peptide backbone (Scheme 1).
Isoaspartic acids are associated with protein aggregation,8,9
most notably in the lens crystallin proteins where isomerization
may induce aggregation10 and promote cataract formation11,12
and in β-amyloid peptides linked to Alzheimer’s disease.8,13,14
Additionally, isoaspartic acids are known to trigger autoimmune
responses,15 which may be involved in diseases such as multiple
sclerosis.16 Importantly, the B cell response triggered by isoAsp
peptides from cytochrome c has been reported to be cross-
reactive, targeting both the isoAsp peptides and the native
protein in mice.17 Low levels of deamidation may, therefore,
trigger the removal of the entire protein population.
As a spontaneous process, the importance of deamidation
extends outside the cell. Deamidation is a source of
heterogeneity in recombinant protein production.18 These
structural changes have been shown to alter protein folding
transitions19 and may contribute to protein aggregation.20
Degradation can continue during storage,4 making deamidation
an important consideration for therapeutic formulations.21
Protein-based bioconjugates represent an increasingly popular
choice for pharmaceuticals,22,23 accentuating the need for better
understanding of effective protein lifetime and degradation
byproducts. For example, perturbations to complementarity-
determining regions (CDRs) of antibodies can drastically
reduce antigen binding efficacy,24 as demonstrated by
deactivation of monoclonal immunoglobulin γ2 following a
single isomerization.25 Furthermore, deamidation is facilitated
by the solvent exposed and flexible nature of CDRs.
Under physiological conditions, deamidation proceeds
through a succinimide intermediate that is formed as the
backbone nitrogen (on the C-terminal side) attacks the side
chain carboxyl group of asparagine26 (Scheme 1). Therefore,
peptide flexibility27 and the amino acid on the C-terminal side
of asparagine strongly influence the deamidation rate.2 Catalysis
by ammonia and increased temperature can accelerate
deamidation.28 Once formed, the asymmetric succinimide
ring can be hydrolyzed to yield Asp or isoAsp with the isoAsp
products being favored at a ratio of about 3:1.26 The ring is
prone to racemization prior to hydrolysis, and the resulting
products include both the L- and D-stereoisomers of Asp and
isoAsp. Asp residues are also susceptible to succinimide ring
formation, ultimately yielding the same four products, but this
reaction is significantly slower.
Despite the ease in detecting deamidation (which results in a
0.984 Da mass shift) via mass spectrometry (MS), high-
throughput analysis of the four isomers generated by
deamidation remains challenging.29 Most chromatographic
methods are limited to reporting the ratio of the Asp/isoAsp,
although some isomeric peptides have been fully resolved via
ultraperformance liquid chromatography (UPLC).12 Addition-
ally, ion mobility MS (IMS-MS) has been successfully
employed to characterize peptide epimers30 and β-amyloid
isomers.31 Mass spectrometry-based dissociation techniques
can be used to detect isoAsp residues based on diagnostic c-
and z- fragment mass shifts generated by electron capture
dissociation (ECD),32 and electron transfer dissociation
(ETD).33 Like ECD and ETD, radical directed dissociation
(RDD) is a gas-phase radical-based dissociation technique, but
RDD differs by generating radicals via site-specific photo-
dissociation.34 Radical migration facilitates cleavage of the
peptide backbone as well as amino acid side chains.35
Importantly, these radical migration pathways are structurally
sensitive.36 RDD has previously been used to distinguish
peptide epimers based on fragmentation patterns37 and identify
Asp isomers via tandem LC-MS.38 Despite these recent
advances, there are few cases where deamidation has been
systematically studied, likely due to time constraints and
difficulty with distinguishing and quantifying the products.
Presented herein is a systematic evaluation of the four Asp
isomers generated via deamidation, with a focus on the
influence of primary peptide sequence, side chain chemistry,
and solvent conditions. Short peptides were selected to test
deamidation in the absence of confounding factors such as
higher-order structure. We analyzed a series of hexapeptides
that vary in sequence by a single amino acid C-terminal to
asparagine. The sequence variations include glycine, which is
side-chain deficient, alanine, which is apolar and has a minimal
steric footprint, serine, which is polar but sterically unimposing,
and finally histidine, which is polar, basic, and bulky. The
peptides were deamidated under physiological, catalytic buffer,
and high heat conditions. By detecting and quantitating all four
isomers, the trends associated with these deamidation
conditions can be identified. Importantly, D-asp and D-isoAsp
were detected in appreciable amounts under all conditions and
were found to significantly increase when deamidation was
carried out in bicarbonate buffer or under elevated temperature
conditions.
■ RESULTS AND DISCUSSION
Mass Spectrometry. All experiments were conducted with
a series of synthetic peptides that varied in sequence by a single
amino acid, 4IB-VKLNXG (where X = G, H, S, A and 4IB =
para-iodobenzoic acid). The half-lives for these peptides at 37
°C in 50 mM Tris at pH 7.8 are 1.4, 6.8, 41, and 73 days,
respectively. Based on related experiments conducted pre-
viously,2 these sequences should be among the fastest to
deamidate while still offering a variety in side chain chemistry.
In addition, 4IB was added to each N-terminus to provide a
photocleavable radical precursor for RDD experiments (see
Supporting Information for structures). Tris has long been
among the buffers of choice to study deamidation in vitro due
to its modest influence on deamidation.39
Following sufficient incubation to deamidate a majority of
the sample, peptides were separated and analyzed via LCMS.
Typical results are shown in Figure 1a, which depicts the ion
chromatogram (extracted from full MS scans for the m/z of the
intact deamidated peptide) for 4IB-VKLDSG after incubation
for 6 months. Only two peaks are apparent, though four Asp
isomers could be generated by the pathways illustrated in
Scheme 1. Given that the structural differences between L-Asp
and D-Asp or L-isoAsp and D-isoAsp are quite subtle, it is likely
that isomers have coeluted. Tandem MS can provide additional
information on this possibility in the form of fragmentation
profiles.
RDD tandem MS results are shown in Figure 1b−d for
locations denoted 1−4, respectively, in Figure 1a. In RDD
experiments, a radical is generated photolytically, and the
product is subjected to collisional activation. Migration of the
radical is structurally sensitive, leading to observation of distinct
fragmentation patterns for isomers. Indeed, close examination
of the spectra shown in Figure 1b−d reveals notable differences.
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The standard method for quantifying such differences is to
calculate an Risomer value, which is obtained from the ratios of
product ions changing the most between two spectra (see
Supporting Information for additional details).40 Risomer values
for all possible pairs from Figure 1b,c were calculated, which
identified the x5 and c4-56L-CO2 fragments as those undergoing
the greatest relative changes. These fragments yield an Risomer
value of 6.3, which is well above the threshold for isomer
identification (>2.4). A similar analysis revealed an Risomer value
of 6.1 for the diagnostic fragments labeled in Figure 1d,e. Fully
annotated spectra are available in the Supporting Information.
The c4-56L-CO2 fragment corresponds to a c4 backbone
fragment that has additionally lost CO2 and 56 Da from the
leucine side chain (i.e., 56L). Such multiple dissociation events
and side chain losses are common in RDD.35 Predicting the
fragments that will yield the maximum Risomer values is not
trivial because changes in fragment abundances are due to
differences in three-dimensional structure (not sequence).
Collision-induced dissociation (CID) was also used to generate
fragmentation spectra for all peptides examined herein, but as a
less structurally sensitive method, CID usually yields lower
Risomer values. The identity of each isomer in Figure 1a can be
determined by comparing spectra from the leading and trailing
edge of each peak to synthetic standards. The spectrum in
Figure 1b best matches that from D-Asp, while Figure 1c
matches L-Asp. The dominant isomer represented at each
labeled point in Figure 1a therefore corresponds to 1 = D-Asp, 2
= L-Asp, 3 = D-isoAsp, and 4 = L-isoAsp. A full list of diagnostic
peaks and Risomer values used for quantitation is provided in the
Supporting Information.
Although the Risomer values readily confirm coelution, they do
not allow quantitation of each isomer. Results from the
synthetic standards for L-Asp and D-Asp isomers of 4IB-
VKLDSG are shown in Figure 2a,b, where again the x5 and c4-
56L-CO2 abundances differ significantly between the spectra.
By plotting the difference/sum of the two diagnostic peaks as a
function of the percent L-Asp, the calibration curve shown in
Figure 2d was generated. Figure 2c shows the averaged
fragmentation pattern obtained from the entire LC peak at
∼23.5 min in Figure 1. While similar to both standards, Figure
2c is not a perfect match to either panel a or panel b of Figure 2
because it contains contributions from both isomers. In order
to quantify the amount of each isomer present, the data from
Figure 2c was mapped onto the calibration curve shown in
Figure 2d. The LC peak at 23.5 min in Figure 1 contains 88% L-
Asp and 12% D-Asp.
This methodology was repeated using both RDD and CID
for each peptide. Calibration curves were generated using the
fragmentation method that afforded the best isomer discrim-
ination. Interestingly, 4IB-VKLNAG separates into three fully
resolved peaks, representing D-Asp, L-Asp, and L-/D-isoAsp.
Quantitation via peak area matched the results derived from the
RDD calibration curve for the ratio of L-Asp and D-Asp to
within 0.5% agreement (see Supporting Information), offering
independent confirmation of our approach.
The results obtained in Tris at pH 7.8 for all four peptide
sequences are summarized in Figure 3. Despite having
considerably different half-lives and side chain chemistry, the
results from all four peptides exhibit similar trends. L-isoAsp is
generated at 68.2% on average and is confirmed to be the
dominant product for each peptide sequence, in agreement
with previous findings.41 In comparison, L-Asp represents only
20.3% of the total deamidation products on average. A similar
preference for the iso-variant is observed between D-isoAsp and
D-Asp, with D-isoAsp present at 9.1% on average compared to
2.4% for D-Asp. The paucity of D-Asp is easily rationalized
because its formation requires both racemization of the
succinimide ring and hydrolysis to open the ring via the less
Figure 1. (a) LCMS chromatogram of the 4IB-VKLDSG deamidation products, which yields only two chromatographic peaks. (b−e) RDD tandem
mass spectra on [4IB-VKLDSG + H]1+ from the leading and trailing edges of the peaks in panel a show differences in fragment intensities that reveal
coeluting isomers within both peaks.
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favorable mechanism. On the other hand, the abundance of D-
isoAsp is significant and illustrates that racemization during
deamidation should not be ignored.
Although deamidation always results in the mutation of
asparagine to aspartic acid, the observation that ∼80% of the
total deamidation products represent unnatural amino acids
may explain the widespread immunogenic responses associated
with deamidation in vivo.42−44 For the same reason,
deamidation in protein therapeutics is likely to have undesirable
effects ranging from loss of activity to altered immunogenic-
ity.44,45 The high abundance of D-isoAsp may also be cause for a
re-examination of previous conclusions discounting its
importance. For example, the presumed-to-be negligible
abundance of D-isoAsp was previously used to rationalize the
substrate specificity of the repair enzyme, protein L-isoaspartate
methyltransferase (PIMT), which can bind L-isoAsp and D-Asp
but not D-isoAsp residues.9 Given that D-Asp is significantly less
abundant than D-isoAsp, PIMT specificity is likely due to other
factors. One potential explanation is that PIMT requires the α-
nitrogen atom to be positioned “behind” the methyl-accepting
carboxyl group as is the case for L-isoAsp and D-Asp, but not L-
Asp or D-isoAsp.41
Buffer Conditions. The influence of buffer, pH, temper-
ature, and ammonia (a known catalyst)28 were explored, and
the results are summarized in Figure 4. To simplify comparison,
the relative abundances of each isomer are plotted together for
all conditions that were examined. The first grouping for each
isomer represents data acquired at 37 °C in 50 mM Tris at pH
7.8 and is derived from the results shown in Figure 3 (replotted
for easy comparison). For all remaining experiments ammonia
was added (indicated by the green box) as ammonium
hydroxide to a final concentration of 100 mM ammonia in
Tris and CHES at each pH or as 100 mM ammonium
bicarbonate for the carbonate buffer. Ammonia has been
reported to accelerate deamidation through general base
catalysis,28 but its influence on deamidation products has not
been previously determined. Although rates are accelerated (as
discussed in greater detail below), the addition of ammonia and
a slight increase to pH 8.8 do not significantly influence the
distribution of Asp isomers generated by deamidation in Tris
buffer (compare Figure 4, Tris 7.8 and Tris 8.8).
Results obtained in CHES buffer at pH 8.8 and 9.8 are also
shown in Figure 4. Although CHES buffer and Tris are
chemically dissimilar and have pKa’s of 9.5 and 8.1,
respectively,46 there is little influence on the overall distribution
of Asp isomers produced by the two buffers. Furthermore,
increasing the pH to 9.8 does not have a significant impact on
the results, though minor variations in product abundance are
noted. Intracellular pH can vary by over 3 pH units, ranging
from 4.7 to 8.0.47 Our data indicate that even the most basic
intracellular conditions are unlikely to strongly influence
succinimide-mediated deamidation products.
The effect of heating was explored by raising the temperature
to 80 °C in CHES at pH 9.8 (these results are marked with an
asterisk in Figure 4). Increasing the temperature impacts the
resulting isomer distribution by decreasing the amounts of L-
Asp and L-isoAsp while increasing the proportion D-Asp and D-
isoAsp at the same time. These results suggest that higher
temperature leads to greater racemization of the intermediate
succinimide ring, leading to greater production of the D-
isomers. After racemization, ring-opening again favors for-
mation of the iso-products. Consequently, elevated temper-
atures used previously to accelerate deamidation in vitro may
have been biased toward the production of the D-isomers.28,48
Interestingly, the increase in D-Asp observed at elevated
temperatures may have prompted an evolutionary adaptation
in the hyperthermophile Pyrococcus furiosus, which expresses a
variant of PIMT that repairs D-Asp containing peptides with
Figure 2. (a,b) Standards of the L-Asp and D-Asp isomers of 4IB-VKLDSG are distinguished by diagnostic fragment peaks. (c) The average
fragmentation abundance for the LC peak that contains both isomers. (d) A calibration curve generated from purified standards reveals the LC peak
contains 88% L-Asp (red square).
Figure 3. Deamidation products at 37 °C in 50 mM Tris at pH 7.8.
Averages are indicated with dashed lines.
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120-fold higher affinity relative to the human enzyme.49 D-
isoAsp, however, is still not a substrate for this variant.
Experiments with bicarbonate buffer at pH 7.7 also revealed
altered isomer product distributions. Although the amount of L-
Asp generated is comparable to other buffers, the production of
L-isoAsp is significantly reduced. This observation suggests that
ring-opening to produce L-isoAsp is specifically disfavored by
the presence of bicarbonate. The isomer abundance that would
typically end up in the L-isoAsp channel is redirected to the D-
isomers, which are both more abundant relative to other buffer
conditions. These results from bicarbonate differ from those
obtained at 80 °C because the increased yield of D-isomers
derives from only L-isoAsp rather than from a diminution of
both L-isomers. The enhanced racemization observed in
bicarbonate is of particular interest because bicarbonate has
been the buffer of choice for many deamidation and digestion
studies.50−52 Bicarbonate also plays a prominent role in the
native blood-buffer system.53 It is surprising that bicarbonate
buffer yields the highest amount of racemization despite having
the lowest initial pH (7.7). Carboxylic acids have been reported
to stabilize deamidation transition states. We attribute the
increase in racemization to noncovalent interactions with
bicarbonate that disfavor formation of L-isoAsp.
Though spontaneous and pervasive, deamidation is typically
slow under physiological conditions, which has deterred large-
scale comprehensive studies and favored examination of
sequences that deamidate quickly. Evaluation of deamidation
can also be complicated by spontaneous degradation for certain
peptide sequences.28,54 These limitations could potentially be
overcome if the rate of deamidation could be accelerated
without biasing the products or favoring other degradation
pathways. Our results suggest that both Tris and CHES based
buffer systems can be used with ammonia as a catalyst over a
wide pH range without significantly influencing the distribution
of Asp isomers that will be formed. However, caution should be
taken if elevated temperature, bicarbonate, or other untested
buffers are to be used. Although the ratio of (total isoaspartic
acids)/(total aspartic acids) has long been the metric of choice
for deamidation studies due to the relative ease of analysis, our
data reveal that the overall product distribution can shift
significantly without changing the isoAsp/Asp ratio. For
instance, the isoAsp/Asp ratio for CHES 9.8 at 37 °C is 3.3
while the ratio at 80 °C is 3.4 despite the noted increase in D-
isomers. Chirally distinct isomers are likely to have different
biological impacts, emphasizing the importance of quantitating
all four isomers.
Rate Enhancement. The degree of rate enhancement
relative to Tris (pH 7.8, 37 °C) is shown as a fold increase in
Figure 5 for each buffer and peptide sequence. On average, Tris
8.8 was found to be 17× faster than Tris 7.8, where potential
acceleration derives from both increased pH and ammonia
catalysis. Comparing CHES at 8.8 and 9.8 reveals that
increasing the buffer by one pH unit yields only a modest
increase in the rate, from 1.2× to 2.0× faster (relative to Tris
7.8). This observation suggests that the bulk of the acceleration
between the Tris samples is due to the presence of ammonia.
This rate enhancement, along with the modest effect on isomer
product distributions shown above, suggests ammonia is a
viable catalyst for deamidation studies.
The most dramatic average rate increase (81×) was observed
by increasing the temperature to 80 °C in CHES. At this
temperature, over three-quarters of 4IB-VKLNGG was
deamidated within 30 min, making it difficult to determine
the deamidation rate accurately. The reported rate increase for
this peptide in Figure 5 is likely accompanied by significant
uncertainty, though deamidation clearly occurs rapidly.
Although elevated temperature appears to provide the greatest
Figure 4. Total product outcomes from 6 different buffer conditions. Averages are depicted with horizontal bars. Green box indicates ammonia
catalysis. The asterisk indicates 80 °C.
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increase in deamidation rate, higher temperature also influences
the product distribution, and yields increased racemization.
Strikingly, the rate of acceleration varies greatly among
different peptide sequences. Most notably, the histidine-
containing peptide is least affected by the addition of ammonia.
This result is particularly interesting because peptides with
asparagine followed by histidine have previously attracted
attention due to their rapid deamidation rates despite the bulky
nature of histidine. Ultimately, this rate enhancement has been
attributed to the ability of the histidine side chain to act as a
general base.54 If true, the addition of ammonia, which also
enhances the rate of deamidation by general base catalysis,28
would not be expected to have a significant effect, in agreement
with the results in Figure 5. Importantly, the histidine peptide
does deamidate more quickly at increased temperature, which
has little effect on acid/base chemistry but increases the energy
available to the system. This observation further confirms that
the basic side chain of histidine likely explains the lack of
response to the addition of ammonia.
Curiously, the rate of deamidation does not increase as
significantly with ammonia for 4IB-VKLNGG in bicarbonate,
though increases for this peptide were comparable to the other
nonhistidine residues in all other conditions. This result may
suggest that carbonate interacts strongly with the backbone,
inhibiting access to the required transition state. The absence of
a side chain for the glycine peptide may increase interactions
between carbonate and the backbone.
■ CONCLUSIONS
Although deamidation yields similar product trends among
vastly different buffer conditions and peptide sequences, it is
noticeably sensitive to specific extrinsic factors. Both bicar-
bonate buffer and high temperature strongly promote
racemization, while increasing pH from 7.8−9.8 has a
surprisingly limited effect. Importantly, we have observed that
D-isomers, which are often ignored, are generated in appreciable
quantities under all conditions. These results establish the
innate deamidation tendencies for all four Asp products and
demonstrate that isomer distributions are susceptible to
external influences. Furthermore, this methodology should be
able to quantify isomers for many classes of peptides, including
isomers identified in proteomics experiments targeting long-
lived proteins relevant to aging, human disease, and biological
therapeutics. Understanding the products of deamidation, and
the factors that alter them should facilitate more reliable
prediction and control of degradation products. This
information may become integral for engineering proteins
that minimize the detrimental effects of deamidation and
isomerization.
■ METHODS
Materials. Organic solvents and reagents were purchased from
Fisher Scientific or Acros Organics and used without further
purification. Water was purified to 18.2 MΩ using a Millipore 147.
FMOC-protected amino acids and Wang resins were purchased from
Anaspec, Inc. or Chem-Impex International.
Peptide Synthesis. Peptides were synthesized manually following
an accelerated FMOC-protected solid-phase peptide synthesis
protocol.55 Para-iodobenzoic acid (4IB) was attached to the N-
terminus of the nascent polypeptide during synthesis. Following
synthesis, peptides were purified using a Phenomenex Jupiter Proteo
C12 4 μm 90 Å 250 mm × 4.6 mm column. Purified peptides were
stored frozen in 50/50 acetonitrile/water (v/v).
Deamidation. Peptides were deamidated in various conditions to
explore the impact of buffer, pH, ammonia catalysis, and temperature.
Tris (50 mM, pH 7.8) at 37 °C results are quantitated and used as
reference values for subsequent comparisons, which include 50 mM
Tris, pH 8.8, + 100 mM NH3 at 37 °C, 50 mM CHES, pH 8.8, + 100
mM NH3 at 37 °C, 50 mM CHES, pH 9.8, + 100 mM NH3 at 37 °C,
100 mM ammonium bicarbonate at 37 °C, and 50 mM CHES + 100
mM NH3 at 80 °C. For the Tris and CHES buffers at pH 8.8 and 9.8,
ammonium hydroxide was added at 381 and 128 mM, respectively, to
yield a final concentration of 100 mM unprotonated ammonia.
Analysis. Following deamidation, peptides were analyzed via
LCMS. An Agilent 1100 binary pump was used with a 5 μm 100 Å
C5 50 mm × 2 mm column (Phenomenex) interfaced to a Thermo
Fisher Scientific LTQ mass spectrometer with a standard electrospray
ionization source. Deamidated peptides were eluted with an isocratic
mixture of 18% acetonitrile and 82% water with 0.1% formic acid (v/
v). Synthetic standards were prepared as ∼10 μM samples in 49.5/
49.5/1 methanol/water/acetic acid (v/v) and infused into a modified
LTQ linear ion trap using the standard electrospray ionization source.
The LTQ was modified with a quartz window to allow fourth
harmonic (266 nm) laser pulses from a Nd:YAG laser to irradiate the
trapped ion cloud, which allows for photoinitiated radical directed
dissociation.56
Risomer Values. Isomers are distinguished based on MS
n
fragmentation spectra. To quantitatively evaluate the differences
between two spectra, Risomer values are calculated using eq 1 where
R1 and R2 refer to the ratios of a pair of fragment ions that vary the
most in abundance between two different MSn scans.
=R R
Risomer
1
2 (1)
Identical fragmentation patterns result in Risomer values of 1, thereby
indicating no discrimination, while larger values reflect a higher degree
of discrimination. Values >2.4 obtained via LCMS are indicative of
analytes that can be distinguished based on fragmentation patterns.38
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C. (2008) Critical Evaluation of Buffering Solutions for pKa
Determination by Capillary Electrophoresis. Electrophoresis 29,
2841−2851.
(47) Chen, S., Hong, Y., Liu, Y., Liu, J., Leung, C. W. T., Li, M.,
Kwok, R. T. K., Zhao, E., Lam, J. W. Y., Yu, Y., and Tang, B. Z. (2013)
Full-Range Intracellular pH Sensing by an Aggregation-Induced
Emission-Active Two-Channel Ratiometric Fluorogen. J. Am. Chem.
Soc. 135, 4926−4929.
(48) Conrad, U., Fahr, A., and Scriba, G. K. E. (2010) Kinetics of
aspartic acid isomerization and enantiomerization in model aspartyl
tripeptides under forced conditions. J. Pharm. Sci. 99, 4162−4173.
(49) Thapar, N., Griffith, S. C., Yeates, T. O., and Clarke, S. (2002)
Protein Repair Methyltransferase from the Hyperthermophilic
Archaeon Pyrococcus Furiosus: Unusual Methyl-Accepting Affinity for
D-Aspartyl and N-Succinyl-Containing Peptides. J. Biol. Chem. 277,
1058−1065.
(50) Li, X., Cournoyer, J. J., Lin, C., and O’Connor, P. B. (2008) Use
of 18O Labels to Monitor Deamidation during Protein and Peptide
Sample Processing. J. Am. Soc. Mass Spectrom. 19, 855−864.
(51) Krokhin, O. V., Antonovici, M., Ens, W., Wilkins, J. A., and
Standing, K. G. (2006) Deamidation of -Asn-Gly- Sequences during
Sample Preparation for Proteomics: Consequences for MALDI and
HPLC-MALDI Analysis. Anal. Chem. 78, 6645−6650.
(52) Liu, S., Moulton, K. R., Auclair, J. R., and Zhou, Z. S. (2016)
Mildly Acidic Conditions Eliminate Deamidation Artifact during
Proteolysis: Digestion with Endoprotease Glu-C at pH 4.5. Amino
Acids 48, 1059−1067.
(53) Siggaard-Andersen, O., and Fogh-Andersen, N. (1995) Base
Excess or Buffer Base (Strong Ion Difference) as Measure of a Non-
Respiratory Acid-Base Disturbance. Acta Anaesthesiol. Scand. 39, 123−
128.
(54) Goolcharran, C., Stauffer, L. L., Cleland, J. L., and Borchardt, R.
T. (2000) The Effects of a Histidine Residue on the C-Terminal Side
of an Asparaginyl Residue on the Rate of Deamidation Using Model
Pentapeptides,. J. Pharm. Sci. 89, 818−825.
(55) Hood, C. A., Fuentes, G., Patel, H., Page, K., Menakuru, M., and
Park, J. H. (2008) Fast Conventional Fmoc Solid-Phase Peptide
Synthesis with HCTU. J. Pept. Sci. 14, 97−101.
(56) Ly, T., and Julian, R. R. (2008) Residue-Specific Radical-
Directed Dissociation of Whole Proteins in the Gas Phase. J. Am.
Chem. Soc. 130, 351−358.
ACS Chemical Biology Articles
DOI: 10.1021/acschembio.7b00686
ACS Chem. Biol. 2017, 12, 2875−2882
2882
